Citadel Advisors
AHI

Citadel Advisors’s Advanced Health Intelligence Ltd AHI Stock Holding History

Citadel Advisors’s Portfolio AHI Stock Details AHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,369
Closed -$16K – 16105
2022
Q3 		$16K Buy
+7,369
New +$19.5K ﹤0.01% 12156

Other funds holding AHI

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Citadel Advisors's AHI Position: Q4 2022 in Review

Citadel Advisors sold out of Advanced Health Intelligence Ltd (AHI) in Q4 2022, closing a stake of 7,369 shares — an estimated $16K sold.

Citadel Advisors first reported a position in AHI in Q3 2022 and held it in 1 quarter. The position peaked at $16K in Q3 2022. 7 funds tracked by Wall St. Rank hold AHI as of Q4 2022.

  • Citadel Advisors reported no remaining Advanced Health Intelligence Ltd position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 7,369 Advanced Health Intelligence Ltd shares in Q4 2022, an estimated $16K.
  • Citadel Advisors first reported a position in Advanced Health Intelligence Ltd in Q3 2022 and held it in 1 quarter.
  • Citadel Advisors's Advanced Health Intelligence Ltd position peaked at $16K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Advanced Health Intelligence Ltd as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.